Global Women's Health Technology Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX over the forecast period 2022-2029. Women's health technology refers to the use of medical devices, software, and digital tools that are specifically designed to address women's unique health needs. It encompasses a wide range of technologies that can help women manage their health, including tools for reproductive health, menstrual cycle tracking, breast health, menopause, pregnancy, and more. These technologies are designed to provide women with personalized and effective healthcare solutions that cater to their specific needs and empower them to take control of their health and well-being. The market demand is primarily driven by the factors such as increased awareness and demand for personalized healthcare, greater emphasis on preventative healthcare by providing tools for early detection and prevention of health issues which prevent the onset of chronic diseases.
In addition, with increasing female presence in healthcare as providers, researchers, and innovators, there is a growing emphasis on addressing women's specific health needs. This has led to increased investment and development of women's health technology. According to World Health Organization (WHO), Women make approximately 67% of the worldwide health and social care workforce. It is estimated that women provide significant health services to around 5 billion people worldwide. Women's contributions to health-care systems are estimated to be worth more than USD 3 trillion every year. Furthermore, the increasing investments towards the research & development of women's health, as well as the development of new diagnostic and treatment technologies are presenting lucrative opportunities for market growth over the forthcoming years. However, regulatory processes could be time-consuming and expensive which can limit the investment for new products, that is restricting the market growth over the forecast period of 2022-2029.
The key regions considered for the Global Women's Health Technology Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the substantial investments made by the major businesses in the invention of creative solutions and technologies for women's health. Also, the prevalence of disorders including post-menopausal syndromes, breast cancer, pelvic or ureteral cancer, and others are rising. Whereas, Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factors such as the increase in birth rates, more knowledge of women's health technology, and other health concerns are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
- Chiaro Technology Ltd
- NaturalCycles Nordic AB
- Ava Science Inc.
- UE LifeSciences Inc.
- Aspect Imaging Ltd.
- Celmatix Inc.
- Assurex Health Inc.
- Rho Capital Partners
- Evofem Biosciences Inc.
- Embr Labs
Recent Developments in the Market:
- In October 2022, Iraq and Afghanistan Veterans of America (IAVA), the main voice of the post-9/11 generation of veterans, is delighted to announce its new relationship with Assurex Health, which is now Myriad Neuroscience Genetics, Inc., a leading genetic testing and precision medicine firm. The GeneSight® test is available to assist doctors to understand how a patient's genes may influence how they metabolise and/or respond to certain drugs routinely used for depression, anxiety, ADHD, and other mental illnesses.
- In November 2021, Ava, the first FDA-cleared fertility tracking wearable, announced that it will now be available as a workplace family-building benefit support tool through a partnership with WINFertility (WIN), the nation's leading fertility benefits management company with the largest employer client portfolio. The collaboration will enable WIN to make the Ava bracelet available to its members, providing an alternative route to data-driven technology that boosts the possibilities of natural conception.
Global Women's Health Technology Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Technology type, Indication, End Users, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology type:
- Surgical
- Diagnostic
- Contraceptive
- Labor & Delivery
- Critical Care
By Indication:
- Cancer
- Infertility
- Menstruation
- Pregnancy
- Post-menopausal Syndrome
- Pelvic Disorders
- Infectious Diseases
By End Users:
- Hospitals
- Obstetrics & Gynaecology Clinics
- Diagnostics Laboratory
- Ambulatory Surgery Centers (ASC)
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- ROLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Women's Health Technology Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Women's Health Technology Market, by Technology type, 2019-2029 (USD Billion)
- 1.2.3. Women's Health Technology Market, by Indication, 2019-2029 (USD Billion)
- 1.2.4. Women's Health Technology Market, by End Users, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Women's Health Technology Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Women's Health Technology Market Dynamics
- 3.1. Women's Health Technology Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Increased awareness and demand for personalized healthcare.
- 3.1.1.2. Emphasis on preventative healthcare.
- 3.1.1.3. Growing female representation in healthcare as providers, researchers, and innovators.
- 3.1.2. Market Challenges
- 3.1.2.1. Regulatory processes could be time-consuming and expensive.
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing investments towards research & development.
- 3.1.3.2. Development of new diagnostic and treatment technologies.
Chapter 4. Global Women's Health Technology Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Women's Health Technology Market, by Technology type
- 6.1. Market Snapshot
- 6.2. Global Women's Health Technology Market by Technology type, Performance - Potential Analysis
- 6.3. Global Women's Health Technology Market Estimates & Forecasts by Technology type 2019-2029 (USD Billion)
- 6.4. Women's Health Technology Market, Sub Segment Analysis
- 6.4.1. Surgical
- 6.4.2. Diagnostic
- 6.4.3. Contraceptive
- 6.4.4. Labor & Delivery
- 6.4.5. Critical Care
Chapter 7. Global Women's Health Technology Market, by Indication
- 7.1. Market Snapshot
- 7.2. Global Women's Health Technology Market by Indication, Performance - Potential Analysis
- 7.3. Global Women's Health Technology Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
- 7.4. Women's Health Technology Market, Sub Segment Analysis
- 7.4.1. Cancer
- 7.4.2. Infertility
- 7.4.3. Menstruation
- 7.4.4. Pregnancy
- 7.4.5. Post-Menopausal Syndrome
- 7.4.6. Pelvic Disorders
- 7.4.7. Infectious Diseases
Chapter 8. Global Women's Health Technology Market, by End Users
- 8.1. Market Snapshot
- 8.2. Global Women's Health Technology Market by End Users, Performance - Potential Analysis
- 8.3. Global Women's Health Technology Market Estimates & Forecasts by End Users 2019-2029 (USD Billion)
- 8.4. Women's Health Technology Market, Sub Segment Analysis
- 8.4.1. Hospitals
- 8.4.2. Obstetrics and Gynaecology Clinics
- 8.4.3. Diagnostic Laboratory
- 8.4.4. Ambulatory Surgery Centers (ASC)
Chapter 9. Global Women's Health Technology Market, Regional Analysis
- 9.1. Women's Health Technology Market, Regional Market Snapshot
- 9.2. North America Women's Health Technology Market
- 9.2.1. U.S. Women's Health Technology Market
- 9.2.1.1. Technology type breakdown estimates & forecasts, 2019-2029
- 9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
- 9.2.1.3. End Users breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Women's Health Technology Market
- 9.3. Europe Women's Health Technology Market Snapshot
- 9.3.1. U.K. Women's Health Technology Market
- 9.3.2. Germany Women's Health Technology Market
- 9.3.3. France Women's Health Technology Market
- 9.3.4. Spain Women's Health Technology Market
- 9.3.5. Italy Women's Health Technology Market
- 9.3.6. Rest of Europe Women's Health Technology Market
- 9.4. Asia-Pacific Women's Health Technology Market Snapshot
- 9.4.1. China Women's Health Technology Market
- 9.4.2. India Women's Health Technology Market
- 9.4.3. Japan Women's Health Technology Market
- 9.4.4. Australia Women's Health Technology Market
- 9.4.5. South Korea Women's Health Technology Market
- 9.4.6. Rest of Asia Pacific Women's Health Technology Market
- 9.5. Latin America Women's Health Technology Market Snapshot
- 9.5.1. Brazil Women's Health Technology Market
- 9.5.2. Mexico Women's Health Technology Market
- 9.5.3. Rest of Latin America Women's Health Technology Market
- 9.6. Rest of The World Women's Health Technology Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Chiaro Technology Ltd
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. NaturalCycles Nordic AB
- 10.2.3. Ava Science Inc.
- 10.2.4. UE LifeSciences Inc.
- 10.2.5. Aspect Imaging Ltd.
- 10.2.6. Celmatix Inc.
- 10.2.7. Assurex Health Inc.
- 10.2.8. Rho Capital Partners
- 10.2.9. Evofem Biosciences Inc.
- 10.2.10. Embr Labs
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption